High-Performance Liquid Chromatographic Method for Analysis of Emtricitabine in Rat Plasma: Method Development, Validation and Application to a Pharmacokinetic Study
Open Access
- 30 November 2013
- journal article
- research article
- Published by Wiley in ISRN Chromatography
- Vol. 2013, 1-6
Abstract
A new reverse phase liquid chromatographic method for the investigation of emtricitabine in rat plasma was developed after oral administration to Wistar rats. The desired chromatographic separation was achieved on Phenomenex C18 column (250mm × 4.6mm I.D., 5µm) column, under isocratic conditions using UV detection at 280nm. The optimized mobile phase consisted of a mixture of 10mM potassium dihydrogen phosphate buffer- (adjusted to pH 6.8) methanol-2% acetic acid in a ratio of (73:25:2, v/v/v) at a flow rate of 1mLmin−1. The system was found to produce sharp and well-resolved peaks for emtricitabine with retention time of 5.78min. The linear regression analysis for the calibration curves showed a good linear correlation over the concentration range 0.0503.0µgmL−1, with determination coefficients, , exceeding 0.9970. The limits of detection (LOD) and quantitation (LOQ) were found to be 0.016µgmL−1 and 0.049µgmL−1, respectively. The method was successfully applied for the pharmacokinetic in rats. Emtricitabine concentration in plasma reached () was 1.357µgmL−1 about 2h after oral administration of 15mg/kg/rat. The AUC0-24 was 12.175µgmL−1* h and the apparent elimination half-life () was 8.153h. This method was found to be suitable for examining emtricitabine concentration in rats, after oral administration of emtricitabine in a single dose.Keywords
Funding Information
- Indian Council of Medical Research (45/38/2011/Nan-BMS)
This publication has 11 references indexed in Scilit:
- Cefpodoxime Proxetil: A New Stability Indicating RP-HPLC MethodISRN Chromatography, 2013
- A Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Tenofovir, Emtricitabine, and a Efavirenz and Statistical Approach to Determine the Effect of VariablesISRN Chromatography, 2013
- HPLC Method for the Determination of Emtricitabine and Related Degradation SubstancesJournal of Chromatographic Science, 2012
- Liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence studyJournal of Pharmaceutical and Biomedical Analysis, 2008
- In Vitro Pre- and Post-Exposure Prophylaxis Using HIV Inhibitors as Microbicides Against Cell-Free or Cell-Associated HIV-1 InfectionAntiviral Chemistry and Chemotherapy, 2007
- Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extractionJournal of Chromatography B, 2005
- In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus MicrobicidesAntimicrobial Agents and Chemotherapy, 2004
- Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected ChildrenAntimicrobial Agents and Chemotherapy, 2004
- Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulationAIDS, 2003
- Quantitation of Intracellular Triphosphate of Emtricitabine in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 1999